Position in ALKS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$145,039,257
-$24,365 QoQ
Shares Held
4,101,789
-20.9% QoQ
Ownership
2.46%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 90.91206300470355.ToString("F0")%
Shared 0.ToString("F0")%
None 9.087936995296443.ToString("F0")%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $2,053,486,048 across 61 Drug Manufacturers - Specialty & Generic names. ALKS ranks #4 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
5,442,067 | $716,937,900 | |
| 2 | ZTS |
Zoetis Inc.
|
3,387,174 | $400,397,831 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,762,744 | $203,693,847 | |
| 4 | ALKS |
Alkermes plc.
This page
|
4,101,789 | $145,039,257 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
5,240,816 | $108,799,337 | |
| 6 | HLN |
Haleon plc
|
8,279,468 | $82,877,469 | |
| 7 | VTRS |
Viatris Inc
|
5,731,565 | $77,433,437 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
4,371,378 | $60,543,580 |
All Filings in ALKS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $145,039,257 | 4,101,789 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $145,063,622 | 5,184,547 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $117,845,100 | 3,928,170 | Shares | Defined | 2025-11-26 | |
| 2025-06-30 | $138,366,368 | 4,836,294 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $172,859,532 | 5,234,995 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $25,581,212 | 889,472 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $10,062,684 | 359,510 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $9,786,694 | 406,087 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $15,367,421 | 567,692 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $16,484,490 | 594,250 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $10,118,807 | 361,257 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $10,889,801 | 347,917 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $9,060,575 | 321,411 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $7,171,848 | 274,468 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $6,237,505 | 279,333 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,197,730 | 275,184 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $4,368,748 | 166,049 | Shares | Defined | 2022-05-11 | |
| 2021-06-30 | $3,252,626 | 132,652 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $1,365,564 | 73,103 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $27,171 | 1,362 | Shares | Defined | 2021-02-19 | |
| 2020-03-31 | $107,255 | 7,438 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||